Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

In The News

  •   Email
  •   Print
  •   Share

  • Dr. Joaquim Bellmunt led research showing the drug Keytruda helped patients with advanced bladder cancer live longer.

Tags: Immunotherapy

  • Dr. Deborah Schrag talked about ways to better monitor and restrict who receives expensive drugs.


Tags: PatientEducation

  • Dr. Toni Choueiri comments on the efficacy of two drugs for the treatment of metastatic kidney cancer.


Tags: TargetedTherapy

  • Dr. Mehra Golshan commented on why a growing number of women with cancer in one breast are opting to have a double mastectomy.


Tags: BreastCancer

  • Dr. Laurie Glimcher talks about the efficacy of the drug Keytruda in certain cancers.

Tags: Immunotherapy

  • Dr. Matthew Meyerson commented on the Precision Medicine Initiative and viewing every disease as a rare disease.

Tags: BasicResearch

  • Dana-Farber hosted an International Inflammatory Breast Cancer conference to help study the disease by bringing global clinical and research experts and patient advocates together.

Tags: BreastCancer

  • Dr. Geoffrey Oxnard talks about liquid biopsy and how the test can tailor a specific therapy to a patient.

Tags: LungCancer

  • In an editorial, Dr. Anthony V. D’Amico said otherwise healthy prostate cancer patients over 65 might opt for aggressive treatment as soon as they are diagnosed.


Tags: ProstateCancer

  • Dana-Farber's incoming CEO Dr. Laurie Glimcher spoke about her role in helping to develop some of the "cancer moonshot" recommendations.

Tags: TargetedTherapy, CopingWithCancer

Showing 1-10 of 694 items